Tag: International Progressive MS Alliance

Advances in treatment and research.

Recent advances and promising researches

Catch up on advances in treatment and research.

Research advances that could lead to breakthrough treatments in progressive MS

New survey launched by the International Progressive MS Alliance

International Progressive MS Alliance invests €3 million in drug discovery project to develop therapies to stop MS progression.

Answering questions and exploring advances in research

Catch up with the latest webcast on unraveling the mystery of progression and identifying new targets for treatments

Learn about important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS.  

A study funded by the International Progressive MS Alliance shows a blood test may have potential in helping to predict future MS activity and response to therapy.

Catch up on the latest webcast on fatigue treatment and research from the International Progressive MS Alliance

Leaders of the International Progressive MS Alliance have published a paper proposing a global research strategy to prioritise and coordinate the efforts needed to find more and better treatments, and improve quality of life of people living with progressive MS.

Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS

Find out about the lives of seven people affected by progressive MS.

The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’

Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of MS

In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in progressive MS

Watch the International Progressive MS Alliance webcast

A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective treatments for progressive MS.

Global webcast on 4 March

This paper was first published in Nature January 2021

Register for the Progressive MS Alliance's Facebook Live event

The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.

Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS

New research funded by the International Progressive MS Alliance looks at ways that nerve fibres protect themselves from damage.

Watch the International Progressive MS Alliance webcast here

An International Progressive MS Alliance global webcast

Register for the Progressive MS Alliance's Facebook Live event on symptom management and well-being in progressive MS

Progressive MS Awards

The International Progressive MS Alliance is growing!

The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have ruled out three repurposed drugs for the treatment of progressive MS.

A treatment that blocks a type of protein that accumulates in the brain was able to reduce inflammation and damage to nerves in laboratory models of MS.

Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.

More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.

A meeting of minds took place at the recent International Progressive MS Alliance event in London

Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more